PMC:7156806 / 5389-6768
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T33 | 64-72 | SP_7 | denotes | COVID-19 |
T34 | 250-258 | SP_7 | denotes | COVID-19 |
T35 | 605-613 | SP_7 | denotes | COVID-19 |
T36 | 736-742 | UBERON:0002048 | denotes | breath |
T37 | 807-812 | UBERON:0001443 | denotes | chest |
T38 | 881-889 | SP_7 | denotes | COVID-19 |
T39 | 1240-1258 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T40 | 1266-1278 | CHEBI:2955;DG_6;CHEBI:2955 | denotes | azithromycin |
T41 | 1361-1369 | SP_7 | denotes | COVID-19 |
T10596 | 64-72 | SP_7 | denotes | COVID-19 |
T20125 | 250-258 | SP_7 | denotes | COVID-19 |
T31473 | 605-613 | SP_7 | denotes | COVID-19 |
T23333 | 736-742 | UBERON:0002048 | denotes | breath |
T50245 | 807-812 | UBERON:0001443 | denotes | chest |
T62702 | 881-889 | SP_7 | denotes | COVID-19 |
T2390 | 1240-1258 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T61512 | 1266-1278 | CHEBI:2955;DG_6;CHEBI:2955 | denotes | azithromycin |
T99933 | 1361-1369 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T8 | 752-756 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
T9 | 787-793 | Body_part | denotes | sweats | http://purl.org/sig/ont/fma/fma12275 |
T10 | 807-812 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T6 | 787-793 | Body_part | denotes | sweats | http://purl.obolibrary.org/obo/UBERON_0001089 |
T7 | 807-812 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T34 | 64-72 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T35 | 250-258 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T36 | 309-314 | Disease | denotes | SCI/D | http://purl.obolibrary.org/obo/MONDO_0015974 |
T37 | 584-589 | Disease | denotes | SCI/D | http://purl.obolibrary.org/obo/MONDO_0015974 |
T38 | 605-613 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T39 | 871-876 | Disease | denotes | SCI/D | http://purl.obolibrary.org/obo/MONDO_0015974 |
T40 | 881-889 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T41 | 1041-1046 | Disease | denotes | SCI/D | http://purl.obolibrary.org/obo/MONDO_0015974 |
T42 | 1361-1369 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T23 | 45-46 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 73-83 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing is |
T25 | 84-87 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T26 | 259-266 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T27 | 334-336 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T28 | 569-570 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T29 | 807-812 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
T30 | 1347-1348 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T4 | 327-332 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T5 | 370-376 | Chemical | denotes | formal | http://purl.obolibrary.org/obo/CHEBI_48341 |
T6 | 1240-1258 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T7 | 1266-1278 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 708-713 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T3 | 723-742 | Phenotype | denotes | shortness of breath | http://purl.obolibrary.org/obo/HP_0002098 |
T4 | 752-762 | Phenotype | denotes | body aches | http://purl.obolibrary.org/obo/HP_0033047 |
T5 | 773-777 | Phenotype | denotes | pain | http://purl.obolibrary.org/obo/HP_0012531 |
T6 | 807-817 | Phenotype | denotes | chest pain | http://purl.obolibrary.org/obo/HP_0100749 |
T7 | 908-918 | Phenotype | denotes | spasticity | http://purl.obolibrary.org/obo/HP_0001257 |
T8 | 943-949 | Phenotype | denotes | rigors | http://purl.obolibrary.org/obo/HP_0025145 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T44 | 0-315 | Sentence | denotes | When participants were asked if they live in a country in which COVID-19 testing is/has been widely available, 57.4% responded, “yes,” 27.4% responded, “no,” and the remaining 15.2% responded, “I’m not certain.” Only 5.8% of participants had ordered COVID-19 testing for one or more of their outpatients with SCI/D. |
T45 | 316-516 | Sentence | denotes | Among this group, 22% reported that they had not used formal screening guidelines, 9.8% that they had screened “all outpatients,” and 65.9% that they had used guidelines published by their government. |
T46 | 517-657 | Sentence | denotes | Only 4.4% of respondents reported that they had had a patient with SCI/D diagnosed with COVID-19 (70.3% had not and 25.3% were not certain). |
T47 | 658-826 | Sentence | denotes | The most commonly listed presenting symptoms were fever (86.2%), shortness of breath (62.1%), body aches/worsening pain (20.7%), sweats (20.7%), and chest pain (13.8%). |
T48 | 827-992 | Sentence | denotes | However, 10.3% reported their patients with SCI/D and COVID-19 had had increased spasticity, 6.9% that they had had rigors, and 6.9% that they had been asymptomatic. |
T49 | 993-1379 | Sentence | denotes | When asked which treatments their patients with SCI/D and COVID had been offered, 82.8% replied, “strict isolation/quarantine,” 58.6% “emergency room level care/hospitalization,” 20.7% “over the counter medications for symptom relief,” and 27.6% “hydroxychloroquine and/or azithromycin.” Two respondents reported that they had referred their patients to a centralized COVID-19 hospital. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
106 | 5-17 | Species | denotes | participants | Tax:9606 |
107 | 225-237 | Species | denotes | participants | Tax:9606 |
108 | 571-578 | Species | denotes | patient | Tax:9606 |
109 | 857-865 | Species | denotes | patients | Tax:9606 |
110 | 1027-1035 | Species | denotes | patients | Tax:9606 |
111 | 1335-1343 | Species | denotes | patients | Tax:9606 |
112 | 1240-1258 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
113 | 1266-1278 | Chemical | denotes | azithromycin | MESH:D017963 |
114 | 64-72 | Disease | denotes | COVID-19 | MESH:C000657245 |
115 | 250-258 | Disease | denotes | COVID-19 | MESH:C000657245 |
116 | 605-613 | Disease | denotes | COVID-19 | MESH:C000657245 |
117 | 708-713 | Disease | denotes | fever | MESH:D005334 |
118 | 723-742 | Disease | denotes | shortness of breath | MESH:D004417 |
119 | 757-762 | Disease | denotes | aches | MESH:D063806 |
120 | 773-777 | Disease | denotes | pain | MESH:D010146 |
121 | 807-817 | Disease | denotes | chest pain | MESH:D002637 |
122 | 881-889 | Disease | denotes | COVID-19 | MESH:C000657245 |
123 | 908-918 | Disease | denotes | spasticity | MESH:D009128 |
124 | 1051-1056 | Disease | denotes | COVID | MESH:C000657245 |
125 | 1361-1369 | Disease | denotes | COVID-19 | MESH:C000657245 |